Medline MDLN
NASDAQ MDLN
$34.05 -0.64 (-1.84%)
As of: Sep 9, 2026 · 3:59 PM EDT

Medline (MDLN) Revenue (2025 - 2026)

Medline's (MDLN) quarterly Revenue came in at $7.7 billion in Q2 2026, up 11.6% year-over-year from $6.9 billion in Q2 2025, and up 4.53% quarter-over-quarter from $7.4 billion in Q1 2026.

Analysis

Medline (MDLN) Revenue (2025 - 2026) Analysis & Trends

Medline (MDLN) has reported Revenue for 2 consecutive years, with $7.7 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Revenue rose 11.6% year-over-year to $7.7 billion in Q2 2026; TTM through Jun 2026 was $28.6 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $28.4 billion, up 11.47% from the prior year.
  • Revenue was $7.7 billion for Q2 2026 at Medline, up from $7.4 billion in the prior quarter.
  • Over five years, Revenue peaked at $7.7 billion in Q2 2026 and troughed at $6.6 billion in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Becton Dickinson 49.48 Bn 48.62 Bn 2.32 Bn 4.98 Bn
2 Medline 29.24 Bn 26.56 Bn 2.22 Bn 7.69 Bn
3 West Pharmaceutical Services 23.94 Bn 23.51 Bn 329.20 Mn 872.30 Mn
4 Baxter International 12.66 Bn 10.51 Bn 1.03 Bn 2.96 Bn
5 Stevanato Group S.p.A 5.51 Bn 5.40 Bn 100.91 Mn 351.04 Mn
6 Acme United 233.67 Mn 228.63 Mn 26.69 Mn 62.72 Mn
7 Rockwell Medical 31.87 Mn 7.07 Mn 3.24 Mn 17.78 Mn
8 Retractable Technologies 21.39 Mn -18.48 Mn 190,852.00 7.20 Mn
9 United Health Products 9.09 Mn 9.06 Mn - -
10 Cuprina Holdings (Cayman) 7.45 Mn 4.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 7.69 Bn
Mar 28, 2026 7.35 Bn
Jun 28, 2025 6.89 Bn
Mar 29, 2025 6.64 Bn